CG Oncology presents updated corporate deck at Morgan Stanley conference; no specifics in filing excerpt

CG Oncology, Inc.

The filing references a corporate presentation (Exhibit 99.1) provided at the Sept 9, 2025 Morgan Stanley conference.
Only a tagline and partial disclaimer header appear in the exhibit excerpt; no new clinical or financial data are visible.
No material changes or specific milestones were disclosed in the 8-K text itself.
Investors should seek the full presentation for any updated pipeline or financial information.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.